Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Diagnostic and Interventional Imaging
|
March 5, 2015
Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatment
H Beji, C De La Fouchardière, F Desseigne, et al.
Cancer Research
|
February 2, 1999
Neurofibromatosis and early onset of cancers in hMLH1-deficient children
Q Wang, C Lasset, F Desseigne, et al.
Gastroenterologie Clinique Et Biologique
|
December 11, 1999
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost]
S Taieb, E Vaillant, P Pommier, et al.
ESMO Open
|
November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
E Assenat, C de la Fouchardière, F Portales, et al.
Current Oncology (Toronto, Ont.)
|
September 25, 2019
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study
E Bonnet, C Mastier, A Lardy-Cléaud, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 2007
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
M Ychou, F Viret, A Kramar, et al.
Human Genetics
|
September 10, 1999
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer
Q Wang, C Lasset, F Desseigne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2013
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F C Bidard, F Huguet, C Louvet, et al.
International Journal of Cancer
|
December 17, 1997
Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families
Q Wang, F Desseigne, C Lasset, et al.
British Journal of Cancer
|
July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
J-P Delord, J Bennouna, P Artru, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Diagnostic and Interventional Imaging
|
March 5, 2015
Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatment
H Beji, C De La Fouchardière, F Desseigne, et al.
Cancer Research
|
February 2, 1999
Neurofibromatosis and early onset of cancers in hMLH1-deficient children
Q Wang, C Lasset, F Desseigne, et al.
Gastroenterologie Clinique Et Biologique
|
December 11, 1999
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost]
S Taieb, E Vaillant, P Pommier, et al.
ESMO Open
|
November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
E Assenat, C de la Fouchardière, F Portales, et al.
Current Oncology (Toronto, Ont.)
|
September 25, 2019
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study
E Bonnet, C Mastier, A Lardy-Cléaud, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 2007
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
M Ychou, F Viret, A Kramar, et al.
Human Genetics
|
September 10, 1999
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer
Q Wang, C Lasset, F Desseigne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2013
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F C Bidard, F Huguet, C Louvet, et al.
International Journal of Cancer
|
December 17, 1997
Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families
Q Wang, F Desseigne, C Lasset, et al.
British Journal of Cancer
|
July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
J-P Delord, J Bennouna, P Artru, et al.
Page
of 2